相互作用
Crizotinib + Lemborexant
重症度: 重大
Crizotinib and Lemborexant: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Crizotinib is a moderate CYP3A inhibitor and can raise lemborexant exposure. This may increase somnolence, next-day impairment and other CNS effects.
この相互作用をわかりやすく説明すると
Crizotinib and Lemborexant can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Crizotinib belongs to Oncology; Lemborexant belongs to Central Nervous System.
なぜ起こるのか
Crizotinib inhibits CYP3A4-mediated metabolism of lemborexant.
対処法
Avoid the combination where possible. If it is necessary, limit lemborexant to the reduced maximum dose recommended in its labeling for moderate CYP3A inhibitors and monitor for daytime sedation.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、CrizotinibとLemborexantの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を7日間無料でお試し。カード登録不要。
Crizotinibのその他の相互作用
Lemborexantのその他の相互作用
よくある質問
Can I take Crizotinib with Lemborexant?
MediHelp rates the interaction as major. Crizotinib and Lemborexant can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Crizotinib is a moderate CYP3A inhibitor and can raise lemborexant exposure. This may increase somnolence, next-day impairment and other CNS effects.
How serious is the interaction between Crizotinib and Lemborexant?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible. If it is necessary, limit lemborexant to the reduced maximum dose recommended in its labeling for moderate CYP3A inhibitors and monitor for daytime sedation.
What other medicines interact with Crizotinib?
MediHelp also lists interactions of Crizotinib with, for example, Flibanserin, Lomitapide, Lonafarnib. The full list is on the Crizotinib page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
